Details for 2021754882

Up to date per 09.05.2026

Actions

Title / Product Name

KOMBINATION VON EINEM BCL-2/BCL-XL-INHIBITOR MIT OSIMERTINIB

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2021754882

EP Publication Number

3914257

E-Number

1643902

Language

PCT Number

CN21084970

Publication Date

01.12.2021 A

27.12.2023 B1

Registration Date

27.12.2023

AT Publication Date

15.01.2024

Application Date

01.04.2021

Registration Number

Priorities

10.04.2020

PCT/CN2020/084145

31.03.2021

202110344288

IPC

A61K 31/675 20060101AFI20230803BHEP

Maximum Duration of Protection

01.04.2041

Owner

Ascentage Pharma (Suzhou) Co., Ltd.Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215000CN

Ascentage Pharma Group Corp Limited9/F., Wah Yuen Building 149 Queen's Road Central Hong Kong 999077CN

Representative

No representatives present

Inventor

ZHAI, YifanUnit 701, Building B7 218 Xinghu Street Suzhou Industrial Park Jiangsu 215000CN

YANG, DajunUnit 701, Building B7 218 Xinghu Street Suzhou Industrial Park Jiangsu 215000CN